A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Radiomics and radiogenomics of primary liver cancers
2019
Clinical and Molecular Hepatology
Concurrent advancements in imaging and genomic biomarkers have created opportunities to identify non-invasive imaging surrogates of molecular phenotypes. In order to develop such imaging surrogates radiomics and radiogenomics/imaging genomics will be necessary; there has been consistent progress in these fields for primary liver cancers. In this article we evaluate the current status of the field specifically with regards to hepatocellular carcinoma and intrahepatic cholangiocarcinoma,
doi:10.3350/cmh.2018.1007
pmid:30441889
pmcid:PMC6435966
fatcat:rizogcp2cbawfeb7lhqy6bdduq